Therefore, we concluded that moderate-to-severe asthma patients, compared to nonasthmatic control subjects, have increased percentages and numbers of total CD14+, CD14+CD16− (classical monocytes), CD14+CD16+ (intermediate monocytes), and CD14+CD2hi blood circulating monocytes. The gene discussed is CD14; the disease is asthma.